Pricing Log in Create free account

NeuroSense Therapeutics Ltd. (NRSN) vs Alaunos Therapeutics, Inc. (TCRT)

NeuroSense Therapeutics Ltd. and Alaunos Therapeutics, Inc. are both Biotechnology companies. NeuroSense Therapeutics Ltd. and Alaunos Therapeutics, Inc. are of similar size ($6.4M and $6.0M). Across the 8 metrics below, NeuroSense Therapeutics Ltd. leads on 4 and Alaunos Therapeutics, Inc. on 4.

Valuation

Metric NRSN TCRT Biotechnology median
P/E n/m n/m 8.50
P/S n/m 456.87 9.71
P/B n/m 9.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1,552.30 9.21
Earnings yield (406.90%) (72.62%) (33.15%)
Free cash flow yield (444.35%) (20.65%) (25.50%)

Profitability

Metric NRSN TCRT Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (185.95%) (56.36%)
Return on assets 0.00% (128.30%) (48.04%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric NRSN TCRT Biotechnology median
Revenue growth (TTM) — (17.65%) 6.02%
EPS growth (last fiscal year) 18.52% 24.66% 30.26%
Revenue growth, 5-year CAGR — (49.08%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRSN TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.28 0.77 4.72
Net debt to EBITDA 0.01 0.33 0.96

Dividend

Metric NRSN TCRT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NRSN TCRT Biotechnology median
Market cap 6.01m 6.38m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack